METHOD OF DETECTION OF MALIGNANCY Russian patent published in 1999 - IPC

Abstract RU 2139540 C1

FIELD: biology, medicine, oncology. SUBSTANCE: method involves determination of sindican in cells of the first human fluid or tissue sample. This the first sample is taken from the human fluid or tissue where the presence of malignant, premalignant, hyperplastic cells or cells showing morphological alternations as compared with normal cells are suspected. Sindican content is compared in the first sample and with sindican levels in the second biological material. The indicated second sample is taken from fluid or tissue of the same type as the first sample of biological material with exception for that the second sample has normal or less transformed cells as compared with the cells from the first sample. Decreased content of sindican in the indicated first sample of biological material as compared with that in the second sample of biological material indicates the presence of malignant or premalignant alternations in cells of the first sample. Indicated alternations can be presented as malignant transformation, or premalignant transformation, or hyperplasia, or morphological alternation. The source of biological material is physiological fluid: plasma, serum. urea or cerebrospinal liquor. Method carries the information content. EFFECT: improved method of detection. 18 cl, 8 dwg, 5 ex

Similar patents RU2139540C1

Title Year Author Number
SUPPRESSION OF TUMOR CELLS PROLIFERATION BY SYNDECANE-1 ECTODOMAIN 1995
  • Markku Jalkanen
  • Markku Mali
RU2164414C2
VASCULAR ADHESION PROTEIN-1 OF AMINOOXIDASE ACTIVITY 1998
  • Jalkanen Sirpa
  • Salmi Marko
  • Smit Dehjvid Dzhon
  • Bono Petri
RU2204838C2
CANCER MARKER AND THERAPEUTIC TARGET 2008
  • Behlkvill Frehnsis
  • Slehttenaar Vajolet
  • Uilson Dzhulija
  • Van Jaokheh
  • Sk'Oppa Titsiana
RU2529797C2
GENE (LBFL313) FAMILY ASSOCIATED WITH MALIGNANT GROWTH OF PANCREAS 2007
  • Kokh Sang-Seok
  • Song Si-Joung
  • Kim Sun-A
  • Li Jang-Soon
  • Dzeon Sun-Bok
  • Park Eui-Chul
  • Kim Joung-Gun
RU2432399C2
DNA FRAGMENT AND PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT 1994
  • Shvajgkhoffer Fab'En
  • Tok Brjuno
RU2218400C2
POLYPEPTIDE POSSESSING CAPACITY FOR BINDING WITH INTRACELLULAR DOMAIN p-55 OF TNF-RECEPTOR, DNA MOLECULE ENCODING THIS POLYPEPTIDE, EXPRESSION VECTOR AND METHOD FOR PREPARING POLYPEPTIDE 1995
  • Vallakh David
  • Boldin Mark
  • Mett Igor'
  • Varfolomeev Evgenij
RU2273664C2
RECOMBINANT VECTOR OF CLONING 1991
  • Kehrol L. Makleod
RU2116346C1
TREATMENT METHOD AND RELATED AGENTS 2001
  • Vadas Meht'Ju
  • Gehmbl Dzhennifer
  • Ksia Pu
  • Vang Lijun
RU2326690C2
METHOD OF USING AXL AS MARKER OF EPITHELIAL-MESENCHYMAL TRANSITION 2010
  • Lorens Dzhejms Bredli
  • Miklem Devid Robert
  • Akslen Lars
RU2586493C2
ANALYSES AND METHODS USING BIOMARKERS 2005
  • Vagner Klaus V.
RU2410438C2

RU 2 139 540 C1

Authors

Markku Tapani Jalkanen

Pir'O Lena Kjullikki Inki

Jarkko Kir'Javajnen

Sirpa Marianne Leppja

Sakari Markku Mali

Dates

1999-10-10Published

1991-12-19Filed